参考文献/References:
1 Schirrmeister H, Guhlmann A, Eisner K, et al. Sensitivity in detecting osseous lesions depends on anatomic localization:Planar bone scintigraphy versus 18F PET[J]. J Nucl Med, 1999, 40(10):1623-1629.
2 Hawkins RA, Choi Y, Huang SC, et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET[J]. J Nucl Med, 1992,33(5):633-642.
3 Brenner W, Vernon C, Muzi M, et al. Comparison of different quantitative approaches to 18F-fluoride PET scans[J]. J Nucl Med, 2004, 45(9):1493-1500.
4 Even-Sapir E, Metser U, Flusser G, et al. Assessment of malignant skeletal disease:initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT[J]. J Nucl Med, 2004, 45(2):272-278.
5 Lonneux M, Borbath Ⅱ, Berliere M, et al. The place of whole-body PET FDG for the diagnosis of distant recurrence of breast cancer[J]. Clin Positron Imaging, 2000, 3(2):45-49.
6 Gallowitsch HJ, Kresnik E, Gasser J, et al. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma:A comparison to conventional imaging[J]. Invest Radiol, 2003, 38(5):250-256.
7 Gayed I, Vu T, Johnson M, et al. Comparison of bone and 2-deoxy2-[18F]fiuoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer[J]. Mol Imaging Biol, 2003,5(1):26-31.
8 Uematsu T, Yuen S, Yukisawa S, et al. Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer[J]. Am J Roentgenol, 2005, 184(4):1266-1273.
9 Morris MJ, Akhurst T, Osman I, et al. Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer[J]. Urology, 2002, 59(6):913-918.
10 Israel O, Militianu D, Goldberg A, et al. PET-CT assessment of bone metastases-FDG avidity and CT patterns before and after treatment[J]. J Nucl Med, 2004, 45:79P.
11 Metser U, Lerman H, Blank A, et al. Malignant involvement of the spine:Assessment by 18F-FDG PET-CT[J]. J Nucl Med, 2004, 45(2):279-284.
相似文献/References:
[1]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):10.
[2]陈香,赵军.PET-CT在非小细胞肺癌中的应用[J].国际放射医学核医学杂志,2005,29(3):97.
CHEN Xiang,ZHAO Jun.The application value of PET-CT imaging in non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):97.
[3]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):197.
[4]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):201.
[5]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):205.
[6]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209.
DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):209.
[7]华逢春,管一晖,赵军.18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用[J].国际放射医学核医学杂志,2005,29(5):216.
HUA Feng-chun,GUAN Yi-hui,ZHAO Jun.18F-FDG PET and PET-CT imaging in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):216.
[8]黄建敏,付占立,潘莉萍.18F-FDG代谢显像标准摄取值的影响因素[J].国际放射医学核医学杂志,2004,28(1):3.
HUANG Jian-min,FU Zhan-li,PAN Li-ping.Affect factors of the standardized uptake value for metabolic imaging with 18F-fluorine-2-deoxy-D-glucose[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):3.
[9]董爱生.18F-FDG PET在结直肠癌中的临床应用价值[J].国际放射医学核医学杂志,2004,28(1):12.
DONG Ai-sheng.The applications of 18F-FDG PET in colorectal carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):12.
[10]王峰.18F-FDG PET对原发性食管癌和复发性食管癌的诊断价值[J].国际放射医学核医学杂志,2004,28(1):15.
WANG Feng.The value of 18F-FDG PET in the staging of paimary and recurent esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):15.